• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流泪(泪液过多)及其他与每周使用多西他赛相关的眼部表现:被低估的剂量限制性毒性。

Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.

作者信息

Tsalic Medy, Gilboa Michael, Visel Bela, Miller Benjamin, Haim Nissim

机构信息

Department of Oncology, Rambam Medical Center and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

出版信息

Med Oncol. 2006;23(1):57-61. doi: 10.1385/MO:23:1:57.

DOI:10.1385/MO:23:1:57
PMID:16645230
Abstract

PURPOSE

Epiphora due to canalicular stenosis is a recently described side effect of weekly docetaxel. We prospectively evaluated the incidence of this complication and other ocular manifestations in patients treated at our medical center.

PATIENTS AND METHODS

Twenty-one consecutive patients (breast cancer: 14; metastatic non-small cell lung cancer: 6; metastatic nasopharyngeal carcinoma: 1) (female/male: 14/7; age range: 34-78 yr) were treated with weekly docetaxel (35 mg/m2/wk iv for 6 wk, cycles repeated every 49 d). A standard questionnaire regarding epiphora was completed before each dose of docetaxel. Patients who complained of excessive tearing underwent a thorough ophthalmologic evaluation before receiving the next dose.

RESULTS

Epiphora due to stenosis of the lacrimal puncti and canaliculi developed in seven (33%) patients following a cumulative dose of 208-645 mg/m2 (median: 400 mg/m2). Two patients developed complete canalicular stenosis requiring surgery. Epiphora was accompanied by madarosis and ectodermalization of the palpebral and bulbar conjunctiva, complete in five patients. Treatment was discontinued due to epiphora in two (10%) patients. After a median follow-up of 11 mo, four patients still had epiphora.

CONCLUSION

Epiphora due to canalicular stenosis is a frequent complication of weekly docetaxel and might be dose limiting. Irreversible damage requiring surgical intervention may develop despite close monitoring.

摘要

目的

泪小管狭窄所致溢泪是近期报道的每周使用多西他赛的一种副作用。我们前瞻性评估了在本医疗中心接受治疗的患者中这种并发症及其他眼部表现的发生率。

患者与方法

连续21例患者(乳腺癌:14例;转移性非小细胞肺癌:6例;转移性鼻咽癌:1例)(女性/男性:14/7;年龄范围:34 - 78岁)接受每周一次的多西他赛治疗(35 mg/m²/周,静脉注射,共6周,每49天重复一个周期)。在每次多西他赛给药前完成一份关于溢泪的标准问卷。主诉流泪过多的患者在接受下一剂药物前接受全面的眼科评估。

结果

在累积剂量达208 - 645 mg/m²(中位数:400 mg/m²)后,7例(33%)患者出现泪点和泪小管狭窄所致溢泪。2例患者出现完全性泪小管狭窄,需要手术治疗。溢泪伴有睫毛脱落以及睑结膜和球结膜的外胚层化,5例患者表现完全。2例(10%)患者因溢泪而停药。中位随访11个月后,4例患者仍有溢泪症状。

结论

泪小管狭窄所致溢泪是每周使用多西他赛常见的并发症,可能会限制剂量。尽管密切监测,仍可能发生需要手术干预的不可逆损伤。

相似文献

1
Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.流泪(泪液过多)及其他与每周使用多西他赛相关的眼部表现:被低估的剂量限制性毒性。
Med Oncol. 2006;23(1):57-61. doi: 10.1385/MO:23:1:57.
2
Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.转移性乳腺癌患者中,每周与每3周使用多西他赛继发的泪小管狭窄。
Ophthalmology. 2002 Jun;109(6):1188-91. doi: 10.1016/s0161-6420(02)00989-2.
3
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.每周使用多西他赛继发的泪小管狭窄:一种可能可预防的副作用。
Ann Oncol. 2002 Feb;13(2):218-21. doi: 10.1093/annonc/mdf036.
4
Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.接受多西他赛治疗的转移性乳腺癌患者泪溢和泪小管狭窄发生率及严重程度的前瞻性研究
J Clin Oncol. 2006 Aug 1;24(22):3619-22. doi: 10.1200/JCO.2005.04.4453.
5
Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.多西他赛治疗的副作用导致泪道引流装置阻塞。
Cancer. 2003 Aug 1;98(3):504-7. doi: 10.1002/cncr.11527.
6
Management of excessive tearing as a side effect of docetaxel.多西他赛副作用所致过度流泪的处理
Clin Breast Cancer. 2005 Feb;5(6):455-7. doi: 10.3816/cbc.2005.n.004.
7
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.多西他赛(泰索帝)继发的泪小管狭窄:一种新认识的副作用。
Ophthalmology. 2001 May;108(5):994-5. doi: 10.1016/s0161-6420(00)00640-0.
8
Docetaxel-associated epiphora.多西他赛相关的泪溢。
Pharmacotherapy. 2006 Jun;26(6):853-67. doi: 10.1592/phco.26.6.853.
9
Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly.多西他赛每周给药患者泪小管狭窄的外科治疗
Arch Ophthalmol. 2001 Dec;119(12):1802-4. doi: 10.1001/archopht.119.12.1802.
10
Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.肉毒杆菌毒素用于泪小管阻塞患者溢泪的姑息治疗。
Ophthalmology. 2005 Aug;112(8):1469-71. doi: 10.1016/j.ophtha.2005.02.022.

引用本文的文献

1
Meibomian gland changes in breast cancer patients treated with docetaxel-partial results.乳腺癌患者接受多西紫杉醇治疗后的睑板腺变化 - 部分结果。
Rom J Ophthalmol. 2023 Apr-Jun;67(2):111-116. doi: 10.22336/rjo.2023.21.
2
Hair disorders in patients with cancer.癌症患者的毛发疾病。
J Am Acad Dermatol. 2019 May;80(5):1179-1196. doi: 10.1016/j.jaad.2018.03.055. Epub 2018 Apr 14.
3
Madarosis: a marker of many maladies.睫毛脱落:多种疾病的一个标志。

本文引用的文献

1
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).一项II期随机试验,比较多西他赛每3周给药一次与每周给药一次作为晚期非小细胞肺癌(NSCLC)患者二线治疗方案的疗效。
Ann Oncol. 2005 Jan;16(1):90-6. doi: 10.1093/annonc/mdi018.
2
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.一项针对转移性乳腺癌患者的多中心、随机II期研究,比较每周或每3周使用多西他赛的疗效。
Ann Oncol. 2004 Sep;15(9):1358-65. doi: 10.1093/annonc/mdh349.
3
Docetaxel secretion in tears: association with lacrimal drainage obstruction.
Int J Trichology. 2012 Jan;4(1):3-18. doi: 10.4103/0974-7753.96079.
4
Breast cancer medications and vision: effects of treatments for early-stage disease.乳腺癌药物与视力:早期疾病治疗的影响。
Curr Eye Res. 2011 Oct;36(10):867-85. doi: 10.3109/02713683.2011.594202. Epub 2011 Aug 5.
5
A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.多西他赛联合 P-糖蛋白拮抗剂 XR9576 治疗肺癌、卵巢癌和宫颈癌患者的药效学研究。
Clin Cancer Res. 2011 Feb 1;17(3):569-80. doi: 10.1158/1078-0432.CCR-10-1725. Epub 2010 Nov 16.
泪液中多西他赛的分泌:与泪道阻塞的关联。
Arch Ophthalmol. 2002 Sep;120(9):1180-2.
4
Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.转移性乳腺癌患者中,每周与每3周使用多西他赛继发的泪小管狭窄。
Ophthalmology. 2002 Jun;109(6):1188-91. doi: 10.1016/s0161-6420(02)00989-2.
5
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.多西他赛(泰索帝)继发的泪小管狭窄:一种新认识的副作用。
Ophthalmology. 2001 May;108(5):994-5. doi: 10.1016/s0161-6420(00)00640-0.
6
Docetaxel administered on a weekly basis for metastatic breast cancer.多西他赛每周给药用于转移性乳腺癌。
J Clin Oncol. 2000 Mar;18(6):1212-9. doi: 10.1200/JCO.2000.18.6.1212.